CCA LONGEVITY FUND IV (US II), LLC
Raised
$48M
Investors
90
Min Invest
$250,000
Is this your company or fund? Claim this page free.
AltStreet Analysis
·Generated from EDGAR primary sources
CCA Longevity Fund IV (US II), LLC is a Delaware pooled investment fund that has raised $48.2M from 90 investors under Rule 506(b) and Section 3(c) exemptions, with a $250K minimum investment. This is an amended filing with William Corry listed as director. The fund operates as a standalone longevity and biotech-focused vehicle.
This longevity/biotech fund employs the standard 506(b) private placement exemption with a $250K minimum, positioning it in the accessible-HNW tier rather than institutional-only territory. The 90-investor count against $48.2M raised suggests an average commitment of approximately $536K, typical for specialized life sciences funds targeting accredited individuals and family offices.
Data Flags
EDGAR Filing Data
Form D — Primary Source
View on SEC.govFilings on Record
Every filing AltStreet's ledger holds for this CIK, newest first. Each opens the SEC archive folder.
Capital Raise Timeline
2 Form D filings from Jul 21, 2022 to Mar 1, 2023, the latest a D/A.
In the Terminal
Filing events
0
none on file
Critical / warning
0 / 0
0 watch · 0 info
Statements extracted
0
none on file
NAV prints
0
none on file
Offering chains
1
lapsed
Fund family Part of the CCA Longevity Fund family: 12 vehicles across 4 generations · full family and the filing behind each link in the terminal
Investor
- The full fund family and any related vehicles (parallel, feeder, successor, sibling series) with the filing that shows each link
- 1 offering timeline: velocity, share raised, first-sale lag, stalled flags
Pro
- This issuer against its cohort: rank by velocity and share raised among offerings filed the same quarter
- The same events, statements and NAV moves across every issuer, screenable, with unlimited watches and CSV
Counts and dates above are the free record. The values, the series and the comparisons are the seat. Loading your view…
Related Persons (Form D)
Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.
William Corry
Director · Vero Beach, FL
Placement Agents and Sales Compensation (Form D)
Who the issuer reported paying to sell the securities (Form D Item 12), with the FINRA registration number the filer gave. Source: SEC.gov.
PJT Partners LPCRD 171058 on BrokerCheck
Associated broker-dealer: None · New York, NY · Soliciting in all states
Questions About CCA LONGEVITY FUND IV (US II), LLC
Each answer is built from the values on the SEC filing and the AltStreet ledger, not from the issuer's marketing.
What is CCA LONGEVITY FUND IV (US II), LLC?
CCA LONGEVITY FUND IV (US II), LLC is a Delaware limited liability company that filed a Form D with the SEC on March 1, 2023 as a other investment fund. The filing claims Rule 506(b), Section 3(c), Section 3(c)(7) for an offering of pooled investment fund interests. AltStreet links the issuer to CCA LONGEVITY FUND IV (US II), LLC.
Is CCA LONGEVITY FUND IV (US II), LLC legit?
AltStreet does not rate legitimacy; it reports the public record. CCA LONGEVITY FUND IV (US II), LLC filed a Form D with the SEC on March 1, 2023 claiming Rule 506(b), Section 3(c), Section 3(c)(7). A Form D is a notice of an exempt offering, not a review or approval of it. The newest notice reports $48,175,000 sold to 90 investors. AltStreet's enforcement record (SEC, FINRA and state actions) shows no action naming the issuer as of today. The issuer is linked to CCA LONGEVITY FUND IV (US II), LLC, which AltStreet has reviewed. Before investing, confirm the filing on EDGAR, check the seller's registration on FINRA BrokerCheck, and read the offering documents, which a Form D does not include.
Is CCA LONGEVITY FUND IV (US II), LLC registered with or approved by the SEC?
No. A Form D is a notice that an issuer is selling securities under an exemption from registration, and the SEC does not review, approve, or pass on the merits of the offering. The filing shows that CCA LONGEVITY FUND IV (US II), LLC claimed Rule 506(b), Section 3(c), Section 3(c)(7) and disclosed the items the form requires, such as the amount sold, the minimum investment, related persons, and anyone paid to sell the securities. It does not verify the issuer's claims or its business.
How much has CCA LONGEVITY FUND IV (US II), LLC raised?
CCA LONGEVITY FUND IV (US II), LLC reported $48,175,000 sold from 90 investors in an offering of indefinite size as of the Form D filed March 1, 2023.
Who can invest in CCA LONGEVITY FUND IV (US II), LLC?
The offering relies on Rule 506(b), which permits sales to accredited investors and to no more than 35 non-accredited investors who meet a sophistication standard, and prohibits general solicitation. Because the fund also relies on Section 3(c)(7), each investor must be a qualified purchaser, generally an individual with at least $5 million in investments. The filing reports no non-accredited investors. The minimum investment accepted from an outside investor is $250,000.
What is the minimum investment in CCA LONGEVITY FUND IV (US II), LLC?
The Form D lists $250,000 as the minimum investment accepted from any outside investor as of March 1, 2023. Issuers can waive their own minimums, and the figure does not include fees.
Who is selling CCA LONGEVITY FUND IV (US II), LLC and how are they paid?
The Form D names PJT Partners LP (CRD 171058), associated with None as the recipient of sales compensation soliciting in all states.
Who is behind CCA LONGEVITY FUND IV (US II), LLC?
The Form D lists 1 related person: William Corry, director. Form D Item 3 requires executive officers, directors, and promoters of the issuer to be listed.
Where is CCA LONGEVITY FUND IV (US II), LLC located?
The issuer's address on its SEC filings is 3505 Ocean Drive, Vero Beach, FL 32963. Its phone number of record is 412-741-2700. It is organized under the laws of Delaware.
How long is the CCA LONGEVITY FUND IV (US II), LLC offering open?
The issuer indicated that the offering is not intended to last more than one year. An issuer must amend its Form D annually while a continuing offering stays open; 1 amendment is on record for this CIK.
How large is CCA LONGEVITY FUND IV (US II), LLC?
The issuer declined to disclose its net asset value range on the Form D, which the form permits.
Is this your company or fund?
Free claim: add your contact details, website, team and a description to this page. The filed facts stay as filed.
Platform verification: the separate analyst-reviewed program for platforms, with right of reply and a document library.
Data Methodology
Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.